Gov. Andrew M. Cuomo has signed a bill enabling OSI Pharmaceuticals Inc. to expand its operations at Farmingdale State College. The legislation, which passed with overwhelming support in the State Senate and Assembly, establishes the boundaries for the college's Broad Hollow Bioscience Park at 38.5 acres and allows for the construction of a third building. This new structure will house start-up companies while OSI expands into an existing building. The move is expected to create 135 jobs at the college, bolstering Long Island's biotechnology sector.
Long Island's push to attract biotech startups has seen mixed results. The Broad Hollow Bioscience Park, with its recent addition of a 43,000-square-foot building, aims to foster new companies. While OSI Pharmaceuticals is expanding, other firms like Helicon Therapeutics have moved away due to delays. Despite significant investment and low rent incentives, the region’s biotech sector struggles to gain traction, facing challenges such as high costs and stiff competition from established hubs.